Cash from Investing (Quarterly) Chart

View Cash from Investing (Quarterly) for BIMI.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Investing (Quarterly) Chart
Start Trial

Historical Cash from Investing (Quarterly) Data

View and export this data back to 2005. Start Trial.
Date Value
September 30, 2023 -0.6039M
June 30, 2023 0.00
March 31, 2023 0.00
December 31, 2022
September 30, 2022 -0.18M
June 30, 2022 -1.678M
March 31, 2022 1.678M
December 31, 2021 1.108M
September 30, 2021 -1.517M
June 30, 2021 -0.3268M
March 31, 2021 0.0391M
December 31, 2020
September 30, 2020 10.25M
June 30, 2020 0.00
March 31, 2020 0.0952M
December 31, 2019
September 30, 2019 -0.5711M
June 30, 2019 0.00
March 31, 2019 0.00
December 31, 2018 -0.0014M
September 30, 2018 -0.0001M
June 30, 2018 0.0015M
March 31, 2018 0.00
December 31, 2017 -0.0039M
September 30, 2017 0.0063M
Date Value
June 30, 2017 -0.0024M
March 31, 2017 0.00
December 31, 2016 -0.4057M
September 30, 2016 -0.0018M
June 30, 2016 0.00
March 31, 2016 0.00
December 31, 2015 2.481M
September 30, 2015 -0.7221M
June 30, 2015 0.0035M
March 31, 2015 -0.1741M
December 31, 2014 -0.0427M
September 30, 2014 -0.1931M
June 30, 2014 -0.1047M
March 31, 2014 -0.0012M
December 31, 2013 -0.1146M
September 30, 2013 -0.0222M
June 30, 2013 -0.7253M
March 31, 2013 -0.0599M
December 31, 2012 -2.748M
September 30, 2012 -0.0282M
June 30, 2012 -0.4678M
March 31, 2012 -0.0061M
December 31, 2011 -0.3844M
September 30, 2011 -0.211M
June 30, 2011 -2.373M

Cash From Investing Definition

Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.

Read full definition.

Cash from Investing (Quarterly) Range, Past 5 Years

View Cash from Investing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Investing (Quarterly) Benchmarks

View Cash from Investing (Quarterly) Benchmarks
Start Trial
Cencora, Inc. -240.15M
Cardinal Health, Inc. -284.00M
McKesson Corp. 1.024B
Amexdrug Corp. --
Henry Schein, Inc. -13.00M